Literature DB >> 28419816

High Rate of Osteoarthritis After Osteochondritis Dissecans Fragment Excision Compared With Surgical Restoration at a Mean 16-Year Follow-up.

Thomas L Sanders1, Ayoosh Pareek1, Mitchel R Obey1, Nicholas R Johnson1, James L Carey2, Michael J Stuart1, Aaron J Krych1.   

Abstract

BACKGROUND: Osteochondritis dissecans (OCD) is a disorder of subchondral bone that causes adverse effects on the overlying cartilage and commonly affects the knee. The incidence of OCD and its long-term effect on the knee joint are controversial. Hypothesis/Purpose: The purpose of this study was to (1) evaluate the rate of osteoarthritis and knee arthroplasty in a population-based cohort of patients with OCD lesions treated operatively and (2) evaluate factors that may predispose patients to knee osteoarthritis and arthroplasty. The investigators hypothesized that OCD lesions diagnosed after skeletal maturity and treatment with fragment excision would be predictive of a diagnosis of osteoarthritis. STUDY
DESIGN: Cohort study; Level of evidence, 3.
METHODS: The investigators identified 221 patients (mean ± SD age, 26.1 ± 13.6 years) with OCD lesions treated operatively between 1976 and 2010 and followed for 16.3 ± 11.4 years (mean ± SD) from diagnosis. Information related to the diagnosis, laterality of lesion, details of treatment, and progression to osteoarthritis was obtained from the medical record. Surgical treatment was classified as fragment excision, fragment preservation (lesion drilling and/or fragment fixation), or chondral defect grafting (osteochondral allograft or autograft). Factors predictive of osteoarthritis and arthroplasty were examined.
RESULTS: There were 134 patients in the fragment excision group, 78 patients in the fragment preservation group, and 9 patients in the chondral defect grafting group. In the fragment excision group, the cumulative incidence of osteoarthritis was 12.0% at 5 years, 17.0% at 10 years, 26.0% at 15 years, 39.0% at 20 years, and 70% at 30 years. The cumulative incidence of arthroplasty was 2.0% at 5 years, 4.0% at 10 years, 4.0% at 15 years, 10.0% at 20 years, and 32.0% at 30 years. In the fragment preservation group, the cumulative incidence of osteoarthritis was 3.0% at 5 years, 7.0% at 10 years, 16.0% at 15 years, 25.0% at 20 years, and 51% at 30 years. The cumulative incidence of arthroplasty was 0.0% at 5 years, 0.0% at 10 years, 3.0% at 15 years, 6.0% at 20 years, and 11.0% at 30 years. No patients in the chondral defect grafting group developed osteoarthritis or underwent arthroplasty. Body mass index (BMI) greater than 25 kg/m2 (hazard ratio [HR] 3.3; 95% CI, 1.6-7.0), older age at diagnosis (HR 4.9; 95% CI, 1.8-17.3), and fragment excision (HR 2.3; 95% CI, 1.2-4.6) were predictive of osteoarthritis.
CONCLUSION: OCD patients treated with fragment excision have a high rate of osteoarthritis and knee arthroplasty at long-term follow-up. In contrast, patients treated with fragment preservation or chondral defect grafting have lower rates of osteoarthritis and arthroplasty. BMI greater than 25 kg/m2, older age at diagnosis, and fragment excision were predictive of osteoarthritis.

Entities:  

Keywords:  OCD; arthroplasty; osteoarthritis; total knee arthroplasty (TKA)

Mesh:

Year:  2017        PMID: 28419816     DOI: 10.1177/0363546517699846

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  23 in total

Review 1.  Surgical Management of Osteochondral Defects of the Knee: An Educational Review.

Authors:  Matthew Howell; Quintin Liao; Christopher W Gee
Journal:  Curr Rev Musculoskelet Med       Date:  2021-02-15

2.  Microfracture for cartilage repair in the knee: a systematic review of the contemporary literature.

Authors:  Patrick Orth; Liang Gao; Henning Madry
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-01-18       Impact factor: 4.342

Review 3.  Treatment of unstable knee osteochondritis dissecans in the young adult: results and limitations of surgical strategies-The advantages of allografts to address an osteochondral challenge.

Authors:  Giuseppe Filardo; Luca Andriolo; Francesc Soler; Massimo Berruto; Paolo Ferrua; Peter Verdonk; Frederic Rongieras; Dennis C Crawford
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-12-06       Impact factor: 4.342

4.  Neither significant osteoarthritic changes nor deteriorating subjective outcomes occur after hybrid fixation of osteochondritis dissecans in the young adult.

Authors:  L Chadli; C Steltzlen; P Beaufils; C Toanen; N Pujol
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-06-19       Impact factor: 4.342

5.  Sprifermin treatment enhances cartilage integration in an in vitro repair model.

Authors:  Mackenzie L Sennett; Gregory R Meloni; Alexandra J E Farran; Hans Guehring; Robert L Mauck; George R Dodge
Journal:  J Orthop Res       Date:  2018-07-26       Impact factor: 3.494

6.  Matrix-assisted chondrocyte transplantation with bone grafting for knee osteochondritis dissecans: stable results at 12 years.

Authors:  Luca Andriolo; Alessandro Di Martino; Sante Alessandro Altamura; Angelo Boffa; Alberto Poggi; Maurizio Busacca; Stefano Zaffagnini; Giuseppe Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2020-08-18       Impact factor: 4.342

7.  Favourable long-term functional and radiographical outcome after osteoautograft transplantation surgery of the knee: a minimum 10-year follow-up.

Authors:  Elina Ekman; Keijo Mäkelä; Ia Kohonen; Ari Hiltunen; Ari Itälä
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-06-02       Impact factor: 4.342

8.  Osteochondritis Dissecans in the Knee of Skeletally Immature Patients: Rates of Persistent Pain, Osteoarthritis, and Arthroplasty at Mean 14-Years' Follow-Up.

Authors:  Mario Hevesi; Thomas L Sanders; Ayoosh Pareek; Todd A Milbrandt; Bruce A Levy; Michael J Stuart; Daniel B F Saris; Aaron J Krych
Journal:  Cartilage       Date:  2018-07-12       Impact factor: 4.634

9.  Articular Cartilage Repair of the Pediatric and Adolescent Knee with Regard to Minimal Clinically Important Difference: A Systematic Review.

Authors:  Rosa S Valtanen; Armin Arshi; Benjamin V Kelley; Peter D Fabricant; Kristofer J Jones
Journal:  Cartilage       Date:  2018-07-02       Impact factor: 4.634

Review 10.  Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair.

Authors:  Magali Cucchiarini; Henning Madry
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.